Yeast-based pharmacogenomics: An IFOM/IEO project to optimize the objectives of Phase I trials

被引：0
|
作者：
Spitaleri, Gianluca
Ferrari, Elisa
Foiani, Marco
Toffalorio, Francesca
Delmonte, Angelo
de Pas, Tommaso M.
Noberasco, Cristina
Catania, Chiara
de Braud, Filippo
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-2193
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2193
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Yeast-based pharmacogenomics approaches to identify Cisplatin responsive genes
    Ferrari, Elise
    Lucca, Chiara
    Spitaleri, Gianluca
    de Braud, Filippo
    Foiani, Marco
    [J]. CANCER RESEARCH, 2010, 70
  • [2] A phase I trial of a yeast-based therapeutic cancer vaccine targeting CEA.
    Madan, R. A.
    Bilusic, M.
    Hodge, J. W.
    Tsang, K. Y.
    Arlen, P. M.
    Heery, C. R.
    Rauckhorst, M.
    McMahon, S.
    Intrivici, C.
    Ferrara, T. A.
    Cohn, A.
    Apelian, D.
    Franzusoff, A.
    Guo, Z.
    Schlom, J.
    Gulley, J. L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] A phase I trial of a recombinant CEA yeast-based vaccine targeting CEA-expressing cancers.
    Bilusic, Marijo
    Gulley, James L.
    Hodge, James W.
    Tsang, Kwong
    Arlen, Philip M.
    Heery, Christopher Ryan
    Rauckhorst, Myrna
    McMahon, Sheri
    Intrivici, Chiara
    Ferrara, Theresa A.
    Cohn, Allen
    Apelian, David
    Franzusoff, Alex
    Guo, Zhimin
    Schlom, Jeffrey
    Madan, Ravi A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [4] Pharmacogenomics Testing in Phase I Oncology Clinical Trials: Constructive Criticism Is Warranted
    Sissung, Tristan M.
    Figg, William D.
    [J]. CANCERS, 2022, 14 (05)
  • [5] Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury
    Heery, Christopher R.
    Singh, B. Harpreet
    Rauckhorst, Myrna
    Marte, Jennifer L.
    Donahue, Renee N.
    Grenga, Italia
    Rodell, Timothy C.
    Dahut, William
    Arlen, Philip M.
    Madan, Ravi A.
    Schlom, Jeffrey
    Gulley, James L.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2015, 3 (11) : 1248 - 1256
  • [6] A Yeast-Based Screening System for Differential Identification of Poisons and Suppressors of Human Topoisomerase I
    Seddek, Ahmed
    Madeira, Christian
    Annamalai, Thirunavukkarasu
    Mederos, Christopher
    Tiwari, Purushottam B.
    Welch, Aaron Z.
    Tse-Dinh, Yuk-Ching
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2022, 27 (03):
  • [7] A phase I study of a yeast-based therapeutic cancer vaccine, GI-6301, targeting brachyury in patients with metastatic carcinoma
    Singh, Harpreet
    Heery, Christopher Ryan
    Marte, Jennifer L.
    Farsaci, Bonedetto
    Madan, Ravi Amrit
    Coyne, Geraldine Helen O'Sullivan
    Palena, Claudia
    Rodell, Timothy C.
    Schlom, Jeffrey
    Gulley, James L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] A Yeast-Based In Vivo Bioassay to Screen for Class I Phosphatidylinositol 3-Kinase Specific Inhibitors
    Fernandez-Acero, Teresa
    Rodriguez-Escudero, Isabel
    Vicente, Francisca
    Candida Monteiro, Maria
    Tormo, Jose R.
    Cantizani, Juan
    Molina, Maria
    Cid, Victor J.
    [J]. JOURNAL OF BIOMOLECULAR SCREENING, 2012, 17 (08) : 1018 - 1029
  • [9] The magnesium powertrain cast components project: Part I - Accomplishments of phase I and the objectives and plans for the magnesium engine in phase II
    Powell, BR
    Ouiment, LJ
    Allison, JE
    Hines, JA
    Beals, RS
    Kopka, L
    Ried, PP
    [J]. MAGNESIUM TECHNOLOGY 2004, 2004, : 3 - 10
  • [10] Novel Statistical Designs for Phase I/II and Phase II Clinical Trials With Dose-Finding Objectives
    Sverdlov, Oleksandr
    Wong, Weng Kee
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2014, 48 (05) : 601 - 612
12345